Equities

Marizyme Inc

MRZM:QBB

Marizyme Inc

Actions
  • Price (USD)0.072
  • Today's Change-0.023 / -24.21%
  • Shares traded11.00k
  • 1 Year change-42.26%
  • Beta0.4582
Data delayed at least 15 minutes, as of May 03 2024 16:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Marizyme, Inc. is a multi-technology life science company. The Company is engaged in the development and commercialization of medical technologies that improves patient health outcomes. Its products include DuraGraft, MATLOC 1 and Krillase. DuraGraft is a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, thereby reducing the incidence and complications of graft failure and improving clinical outcomes post bypass surgery. MATLOC is a lab-on-chip digital screening and diagnostic device platform, which is being developed for quantitative chronic kidney disease (CKD) assessment. Krillase can be used in the treatment of chronic wounds and burns, and other clinical applications. Its DuraGraft is an endothelial damage inhibitor (EDI), indicated for cardiac bypass, peripheral bypass, and other vascular surgeries.

  • Revenue in USD (TTM)590.91k
  • Net income in USD-79.15m
  • Incorporated2007
  • Employees13.00
  • Location
    Marizyme Inc555 HERITAGE DRIVE, SUITE 205JUPITER 33458United StatesUSA
  • Phone+1 (561) 935-9955
  • Fax+1 (770) 720-1335
  • Websitehttps://marizyme.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Marijuana Company Of America Inc1.50m-13.01m3.09m7.00------2.06-0.0071-0.00710.0003-0.00360.31375.617.64214,085.70-272.25-837.07----28.3739.75-867.96-3,809.920.031-0.6498----267.09159.6516.09------
Kiromic Biopharma Inc0.00-24.99m3.14m31.00---------29.21-29.210.00-3.810.00----0.00-171.18-161.49---213.01-----------15.691.87-------35.90--177.42--
Axim Biotechnologies Inc39.77k-8.06m3.19m6.00------80.16-0.0366-0.03660.0001-0.03110.0095----6,628.33-193.43-154.34---390.73-----20,265.75-36,362.71---0.62----345.05-27.38-29.10------
Applied DNA Sciences Inc9.00m-7.29m3.24m53.00--0.6051--0.3598-10.91-10.9113.566.200.595613.133.99169,733.00-48.39-88.57-59.91-121.9137.6544.35-81.25-113.261.63--0.00---26.4327.92-18.73--33.80--
Scisparc Ltd0.00-6.96m3.26m3.00--36.64-----1.22-1.510.000.03440.00----0.00-92.51-69.39-152.41-111.07-------527.17----0.9371--113.73---97.61------
Mustang Bio Inc0.00-51.60m3.30m80.00--24.91-----6.15-6.150.000.01280.00----0.00-93.68-70.02-129.52-79.98-----------15.560.00------33.44---60.75--
AgriFORCE Growing Systems Ltd16.28k-11.73m3.34m7.00--0.101--205.36-14.14-14.140.0141.470.0008--0.4082,325.71-59.84-78.95-84.37-109.8616.58---72,071.25-243,182.500.6922-1.390.3253------8.85--48.61--
Marizyme Inc590.91k-79.15m3.36m13.00------5.69-1.83-1.830.0139-0.47040.01170.957512.1345,454.62-157.28-29.47-314.26-30.4271.6367.78-13,393.85-8,518.470.025-0.5887----11.0418.20-247.03------
NovaBay Pharmaceuticals Inc14.73m-16.70m3.42m24.00--0.7813--0.2324-3.82-3.823.500.29511.162.1610.78613,583.30-75.81-61.51-114.10-83.8953.6159.99-65.46-86.470.9998--0.2555--2.243.32-2.66---15.46--
Aptevo Therapeutics Inc0.00-18.65m3.55m40.00--0.0358-----77.09-70.570.0027.620.00----0.00-63.16-47.16-86.49-85.03-------583.47----0.00---100.00---365.90------
Atreca Inc0.00-97.76m3.58m90.00--0.3322-----2.49-2.490.000.27150.00----0.00-98.54-44.99-116.19-48.05------------0.00------11.13---8.46--
Yield10 Bioscience Inc60.00k-14.46m3.60m29.00------59.97-50.04-50.040.1815-4.950.01--4.002,068.97-241.08-91.26-524.02-108.09-----24,091.67-2,279.74---------86.67-35.94-6.55--1.84--
Biostax Corp0.00-1.65m3.60m-----------0.0198-0.01980.00-0.04560.00-------193.36-75.14---------------8.97--------53.32------
ENDRA Life Sciences Inc0.00-10.06m3.61m21.00--0.5998-----1.93-1.930.000.54470.00----0.00-125.53-132.00-149.91-157.28------------0.005------23.67---19.46--
Optimus Healthcare Services Inc1.27m-7.79m3.63m17.00------2.87-0.1948-0.19480.0317-0.12910.2595--2.1674,453.53-159.79---2,228.37--77.90---615.77--0.1525-15.4121.18--------------
Data as of May 03 2024. Currency figures normalised to Marizyme Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.